cort125281
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 21, 2017 (NCT03335956)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Glucocorticoid receptorANTAGONIST
NR3C1 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03877952 | Phase 1 | Sep 13, 2018 | Corcept Therapeutics, Quotient |
| NCT03437941 | Phase 1/Phase 2 (Phase 2) | Dec 15, 2017 | Corcept Therapeutics |
| NCT03335956 | Phase 1 | Sep 21, 2017 | Corcept Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Corcept Therapeutics | For profit | 3 | 3 | 2 | 2017 |
| Quotient | For profit | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1